AI Multi-Horizon Analysis
No specific ultra-short-term signals available; market may remain range-bound.
No clear short-term directional signals; current valuation and inventory levels warrant caution.
Fundamental strength and industry tailwinds support a bullish long-term view.
KLA exhibits strong revenue growth, expanding margins, and robust free cash flow, supported by a solid balance sheet and secular industry tailwinds, indicating a bullish long-term outlook.
Detailed AI Fundamental Analysis
KLAC (KLA Corporation) – Fundamental Briefing
Current Price: $1,845.22
Market Cap: $234.0B
Employees: 15,200
Exchange: NASDAQ (Listed 1980-10-08)
Sector: Optical Instruments & Lenses (Semiconductor Capital Equipment)
Business Snapshot
KLA Corporation is a leading supplier of process control and yield management systems for the semiconductor and related nanoelectronics industries. The company’s equipment and software enable chipmakers to detect defects, measure critical dimensions, and optimize manufacturing yields. As a high‑cap provider to the $500B+ semiconductor industry, KLAC benefits from structural demand driven by advanced node transitions (EUV, gate‑all‑around) and rising chip complexity. The business model is capital‑intensive but generates strong recurring service revenue.
Financial Trends (4‑Period Trajectory)
All figures from 10‑Q (quarterly) except 2025‑06‑30 (10‑K annual). Quarterly comparisons are between the three most recent quarters.
Revenue
| Period | Revenue (USD) | ∆ vs Prior Quarter |
|---|---|---|
| 2025‑06‑30 (Annual) | $12,156M | – |
| 2025‑09‑30 (Q1 FY26) | $3,210M | – |
| 2025‑12‑31 (Q2 FY26) | $3,297M | +2.7% |
| 2026‑03‑31 (Q3 FY26) | $3,415M | +3.6% |
Trajectory: Sequential revenue growth is accelerating (from +2.7% to +3.6%), with Q3 reaching a new quarterly high in the dataset. The annual revenue run‑rate (last four quarters ~$12.1B) is roughly in line with FY25 annual revenue, implying no year‑over‑year decline.
Profitability (Net Margin)
| Period | Net Income | Net Margin | ∆ in Margin (pp) |
|---|---|---|---|
| 2025‑06‑30 | $4,062M | 33.41% | – |
| 2025‑09‑30 | $1,121M | 34.93% | +1.52 |
| 2025‑12‑31 | $1,146M | 34.75% | -0.18 |
| 2026‑03‑31 | $1,201M | 35.17% | +0.42 |
Trajectory: Net margin is trending upward, from 33.4% (annual) to a Q3 FY26 quarterly margin of 35.2%. The slight dip in Q2 is reversed in Q3. The consistent ~35% net margin reflects strong pricing power and cost discipline.
Free Cash Flow (FCF)
| Period | Operating CF | CapEx | FCF | ∆ FCF vs Prior Quarter |
|---|---|---|---|---|
| 2025‑09‑30 | $1,162M | $96M | $1,066M | – |
| 2025‑12‑31 | $2,529M | $201M | $2,328M | +118.4% |
| 2026‑03‑31 | $3,237M | $287M | $2,950M | +26.7% |
Trajectory: FCF is surging. Q3 FY26 FCF of $2,950M is nearly triple the Q1 level, driven by strong cash collections and moderate capex increases. The cumulative FCF over the trailing twelve months (TTM) implied by quarterly data is ~$7.7B (Q2+Q3+? For TTM we need Q4 FY25? Not provided, but Q3 FY26 alone is already $2.95B). This indicates exceptional cash generation.
Balance Sheet Strength
| Metric | 2025‑06‑30 | 2026‑03‑31 | ∆ (Period) |
|---|---|---|---|
| Current Ratio | 2.62x | 3.03x | +0.41 |
| Working Capital | $6,613M | $7,599M | +$986M |
| Cash & Equivalents | $2,079M | $1,787M | -$292M |
| Retained Earnings | $2,179M | $3,187M | +$1,008M |
| Total Liabilities | $11,375M | $11,043M | -$332M |
| Shareholders’ Equity | $4,692M | $5,830M | +$1,138M |
Trajectory: The balance sheet is strengthening rapidly. Current ratio improved from 2.62x to 3.03x, indicating ample short‑term liquidity. Total liabilities are declining while equity is rising, reducing leverage. Retained earnings grew by $1.0B (46% increase) reflecting strong net income. Cash dipped in the latest quarter ($2.45B → $1.79B) likely due to share buybacks and/or dividend payments (see financing cash outflow of $2.5B in Q3).
Inventory
| Period | Inventory (Net) | ∆ |
|---|---|---|
| 2025‑06‑30 | $3,212M | – |
| 2025‑09‑30 | $3,297M | +$85M |
| 2025‑12‑31 | $3,283M | -$14M |
| 2026‑03‑31 | $3,437M | +$154M |
Trajectory: Inventory is growing, especially in the latest quarter (+4.7% QoQ). While this could signal building demand (pre‑build for new tools), it also ties up cash and may indicate slower turns. Monitor in context of revenue growth.
Financial Health (Latest Period in Trend Context)
Verdict: Excellent.
- Revenue & Margins: KLA is in a growth phase, with quarterly revenue sequentially accelerating and net margins expanding above 35%. The combination of top‑line growth and margin expansion is a powerful sign of operating leverage.
- Cash Generation: FCF is on a steep upward trajectory. Q3 FY26 FCF of $2.95B represents a ~86% FCF conversion from net income, well above typical industrial levels. This provides ample capacity for R&D, dividends, buybacks, or M&A.
- Liquidity: Current ratio of 3.03x is strong and improving. Cash + short‑term investments ($1.79B) cover current liabilities only partially, but the massive cash flow easily covers near‑term obligations.
- Leverage: Total liabilities declined for three consecutive quarters, while equity grew. The company appears to be actively deleveraging (or repurchasing debt). No explicit debt figure provided, but the improving equity base and declining liabilities suggest a solid balance sheet.
- Risk: Inventory increase (+$154M in Q3) outpaces revenue growth rate. If demand softens, excess inventory could pressure margins. Also, the cash balance dropped $665M QoQ, likely due to aggressive capital return (financing outflow $2.5B). This is not alarming given the cash flow strength, but investors should watch for any unexpected debt needs.
Insider Activity
No insider transactions (Forms 4/5) were reported in the 30‑day period ending 2026‑05‑11. No insider sentiment data is available for the last 90 days.
Implication: Absence of insider selling is neutral; absence of buying is neutral. No signal to confirm or challenge the fundamental picture.
Multi‑Timeframe Technical Context
No price/volume or indicator data was provided. The current price of $1,845.22 and market cap of $234B are the only market inputs available.
Given the lack of technical data (candles, moving averages, RSI, etc.), a technical assessment cannot be performed. Traders should overlay their own chart analysis (support, resistance, volume patterns) on this fundamental framework.
Bull / Bear Cases
Short‑Term (Hours to Days)
Bull:
- Strong Q3 beat on revenue and margins could drive momentum.
- Positive sequential revenue acceleration suggests no near‑term demand weakness.
- Insider absence of selling removes a bearish signal.
- FCF surge may trigger dividend increase or buyback announcement.
Bear:
- Stock is trading at a high absolute price ($1,845) – any market‑wide pullback could trigger profit‑taking.
- Inventory buildup may raise concerns of channel stuffing or slowing end‑demand.
- No insider buying means management may not see deep value at current levels.
Long‑Term (Weeks to Months)
Bull:
- Secular tailwinds from AI, advanced packaging, and next‑gen chip manufacturing (3nm/2nm) support KLA’s equipment demand.
- Expanding net margins and FCF growth provide a strong capital returns story (buybacks, dividends).
- Balance sheet strengthening (current ratio 3.0x, falling liabilities) offers resilience in a downturn.
- KLA is a high‑quality compounder – consistent history of revenue and earnings growth.
Bear:
- Semiconductor cycle risk: capital equipment is cyclical. Any slowdown in chip spending (macro recession, inventory correction) would hit orders.
- Valuation (market cap $234B on TTM net income ~$4.6B?) implies ~51x P/E? Need actual TTM EPS: Q3+Q2+Q1+prior Q4? Not fully provided, but even at high multiples, a growth deceleration would compress the multiple.
- Inventory growth outpaces revenue – if demand falters, write‑downs could pressure margins.
- Heavy financing outflows (buybacks) funded by cash flow – shareholder dilution is minimal but leverage could rise if cash flow drops.
Key Levels & Triggers
Fundamental Catalysts to Watch:
- Next Earnings Report – Likely late July 2026 (Q4 FY26). Revenue guidance and order backlog will be critical.
- Industry Cycle Indicators – PMI, semi equipment billings (SEMI data), major customer capex plans (TSMC, Samsung, Intel).
- Capital Allocation Announcements – Any change in buyback authorization or dividend growth could move the stock.
- Macro / Geopolitical – Export controls on China (KLA’s exposure to Chinese customers), interest rate path, and global GDP growth.
Price Levels (Notional, for reference only; no chart data provided):
- Round numbers ($1,800 / $1,850) may act as psychological support/resistance.
- Given the strong trend, any break below $1,750 could signal a reversal; above $1,900 could attract momentum buyers.
All analysis is based solely on the provided financial data. No earnings guidance, analyst estimates, or external valuation models have been used.
